An interventional study of Hyaluronic Acid (0.2%) and EDTA 24% in GINGIVAL RECESSION, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 53 studies in Gingival Recession with a site in Egypt — 14 open to participants now, 17 under way, 1 of them phase 3. Gingival Recession · Egypt.
Among the 53 studies in Gingival Recession with a site in Egypt, this one is the 9th largest by enrollment of the 50 interventional ones that give a count, is one of 7 that started in 2025, is one of 45 with no phase, and was the 53rd registered.
430 studies on the registry are indexed under Gingival Recession; 106 are open to participants now.
Browse Gingival Recession studies →14 of the 53 studies in Gingival Recession with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18+
Kafrelsheikh University · Sites in Egypt
Ages 21–45 · Healthy volunteers
Cairo University · Sites in Egypt
Ages 18+
Cairo University · Sites in Egypt
Ages 18–60 · Healthy volunteers
Misr International University · Sites in Egypt
Ages 18–55 · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 63 Gingival Recession studies recruiting now, 30 (48%) set no upper age limit and 30 (48%) stop at 75 or younger; 1 takes children under 18; 36 take healthy volunteers.
This study: 25 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 1 · Phase 4 2
First in 2015; this study’s year is marked. 7 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 30 is close to the median of 30 across 394 interventional studies indexed under Gingival Recession.
Median enrollment 24 across the 50 interventional studies, 149 across the 3 observational. Of the 28 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 53 has an industry lead sponsor. The 10 most frequent:
Al-Azhar University is the lead sponsor of 536 studies on the registry; 172 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Al-Azhar University has 3 studies filed under Gingival Recession — fewer than ten, so there is no comparison to draw.
6 of the studies in Gingival Recession with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06643507Phase 3Cairo UniversityEvaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions | 2026-12-20 |
| NCT07526259Cairo UniversityComparative Evaluation of Novel 3D Tunneling Technique Versus Modified Coronally Advanced Tunnel (MCAT) With Connective Tissue Graft in the Management of Multiple RT2 Gingival Recession | 2027-01-10 |
| NCT05688293Misr International UniversityGingival Recession (RT1) Treatment With Different Gingival Augmentation Surgeries | 2027-01-20 |
| NCT07801677Cairo UniversityThe Effect of Vertically Coronally Advanced Flap With Sub-epithelial Connective Tissue Graft Versus Coronally Advanced Flap With Sub-epithelial Connective Tissue Graft on Gingival Recession. | 2027-03 |
| NCT07771244Cairo UniversityHyaluronic Acid and Polynucleotides With Connective Tissue Graft and Coronally Advanced Flap for RT II Gingival Recession | 2027-03-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 53 studies in Gingival Recession with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of this study was to compare the clinical effects of hyaluronic acid (HA) and ethylenediaminetetraacetic acid (EDTA) as adjuncts to the tunnel surgical technique in the management of Miller Class I (RT1) gingival recession defects in the esthetic zone among systemically healthy patients.
A total of 30 systemically healthy patients presenting with RT1 gingival recession defects were randomly allocated into three groups, with 10 patients in each group. All patients underwent surgical treatment using the tunnel technique. In the first group, 0.2% hyaluronic acid gel (Gengigel®) was applied to the exposed root surface and within the prepared tunnel. In the second group, the exposed root surface was conditioned with 24% EDTA for 2 minutes, followed by saline irrigation. The third group received the tunnel technique alone and served as the control group.
Clinical outcomes were evaluated at baseline, 3 months, and 6 months postoperatively. The assessed clinical parameters included recession depth (RD), clinical attachment level (CAL), keratinized tissue width (KTW), probing depth (PD), plaque index (PI), and gingival index (GI), to evaluate changes in periodontal clinical conditions following treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
1- Presence of multiple gingival recession (at least two sites) defects on the labial/buccal surfaces of the teeth either in maxilla or mandible diagnosed as type1 gingival recession (RT1).
2- Radiographic evidence of sufficient interdental bone (the distance between the crestal bone and cementoenamel junction (CEJ) as ≤2 mm).
3- Presence of width of keratinized gingiva (WKG) apical to recession ≥3 mm. 4- Male or female aged from 25 - 40 years old
Exclusion Criteria:
- 1- Smoking patient 2- Pregnancy breastfeeding patients. 3- Patients with systemic conditions which could affect the outcome of periodontal surgery.
4- Previous periodontal therapy in last 6 month
Biological: Hyaluronic Acid (0.2%)
Biological: EDTA 24%
Procedure: tunnel technique
Application of Hyaluronic Acid gel as an adjunct to the tunnel technique.
Application of EDTA as an adjunct to the tunnel technique
Surgical correction of gingival recession using the tunnel technique alone without any adjunct materials.
Percentage of root coverage assessed using a periodontal probe
Root coverage will be assessed clinically using (unc15) periodontal probe at baseline and at 3 and 6 months post-treatment. The percentage of root coverage will be calculated by measuring the reduction in gingival recession depth and comparing it with the baseline measurement. The results will be recorded and compared across the follow-up periods to evaluate the effectiveness of the treatment.
Time frame: 3 month and 6 months from base line
Recession depth
Recession depth will be measured in millimeters using a UNC-15 periodontal probe as the distance from the cemento-enamel junction (CEJ) to the gingival margin. Measurements will be recorded at baseline and at 3 and 6 months post-treatment to evaluate changes in gingival recession depth over time
Time frame: 3 month and 6 months from base line
Keratinized Gingiva
Keratinized gingiva width will be measured in millimeters using a UNC-15 periodontal probe as the distance from the gingival margin to the mucogingival junction. Measurements will be recorded at baseline and at 3 and 6 months post-treatment to evaluate changes in keratinized gingiva width.
Time frame: 3 month and 6 months from base line
Probing depth
Time frame: 3 month and 6 months from base line
Plaque Index
Time frame: 3 month and 6 months from base line
Gingival Index
Time frame: 3 month and 6 months from base line
clinical attachment
Time frame: 3 month and 6 months from base line
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2025 to primary completion in Jan 2026, 3 months.
Of 236 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 3 months is below that.
Counting every sponsor, half of 238 studies reached it within 19 months; a quarter within 11 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Hyaluronic Acid